Grape King Bio Ltd (TPE:1707)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
101.50
-0.50 (-0.49%)
Jun 5, 2026, 1:30 PM CST
Market Cap15.11B -26.4%
Revenue (ttm)10.28B -7.1%
Net Income1.19B -15.2%
EPS7.94 -15.4%
Shares Out 148.14M
PE Ratio12.85
Forward PEn/a
Dividend6.00 (5.91%)
Ex-Dividend DateJun 17, 2026
Volume293,099
Open102.00
Previous Close102.00
Day's Range101.00 - 102.50
52-Week Range99.40 - 138.00
Beta0.20
Analystsn/a
Price Targetn/a
Earnings DateAug 11, 2026

About Grape King Bio

Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company provides health products and supplements; and microbial fermentation for mushroom mycelium, probiotics, and enzymes. It also offers functional ingredients for intestinal care, immunity regulatio... [Read more]

Sector Healthcare
Founded 1969
Employees 501
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1707
Full Company Profile

Financial Performance

In 2025, Grape King Bio's revenue was 10.25 billion, a decrease of -8.14% compared to the previous year's 11.16 billion. Earnings were 1.22 billion, a decrease of -15.88%.

Financial Statements